JP2023511501A5 - - Google Patents
Info
- Publication number
- JP2023511501A5 JP2023511501A5 JP2022538169A JP2022538169A JP2023511501A5 JP 2023511501 A5 JP2023511501 A5 JP 2023511501A5 JP 2022538169 A JP2022538169 A JP 2022538169A JP 2022538169 A JP2022538169 A JP 2022538169A JP 2023511501 A5 JP2023511501 A5 JP 2023511501A5
- Authority
- JP
- Japan
- Prior art keywords
- cpp
- amino acid
- acid sequence
- modified
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2019904882A AU2019904882A0 (en) | 2019-12-20 | Novel Cellular Delivery Methods | |
| AU2019904882 | 2019-12-20 | ||
| PCT/AU2020/051397 WO2021119756A1 (en) | 2019-12-20 | 2020-12-18 | Novel cellular delivery methods |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023511501A JP2023511501A (ja) | 2023-03-20 |
| JP2023511501A5 true JP2023511501A5 (enExample) | 2023-12-21 |
| JP7684971B2 JP7684971B2 (ja) | 2025-05-28 |
Family
ID=76476454
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022538169A Active JP7684971B2 (ja) | 2019-12-20 | 2020-12-18 | 新規の細胞内送達方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US12698307B2 (enExample) |
| EP (1) | EP4077354A4 (enExample) |
| JP (1) | JP7684971B2 (enExample) |
| KR (1) | KR20220117914A (enExample) |
| CN (1) | CN115190884B (enExample) |
| AU (1) | AU2020406670B2 (enExample) |
| BR (1) | BR112022012057A2 (enExample) |
| CA (1) | CA3161901A1 (enExample) |
| IL (1) | IL294050A (enExample) |
| WO (1) | WO2021119756A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019165183A1 (en) | 2018-02-22 | 2019-08-29 | Entrada Therapeutics, Inc. | Compositions and methods for treating mitochondrial neurogastrointestinal encephalopathy |
| CA3161901A1 (en) | 2019-12-20 | 2021-06-24 | Shane Stone | Novel cellular delivery methods |
| US12338437B2 (en) | 2020-05-11 | 2025-06-24 | Stoke Therapeutics, Inc. | OPA1 antisense oligomers for treatment of conditions and diseases |
| EP4469576A4 (en) * | 2022-01-27 | 2026-04-15 | Univ Alberta | Antisense therapeutic products conjugate to pre-MIARN splicing modulating peptides for the treatment of diseases |
| WO2024073042A1 (en) * | 2022-09-30 | 2024-04-04 | Entrada Therapeutics, Inc. | Ocular delivery of therapeutic agents |
| WO2024254639A1 (en) * | 2023-06-16 | 2024-12-19 | PYC Therapeutics Limited | Compositions and methods for treatment of kidney disease |
| WO2025238644A1 (en) * | 2024-05-16 | 2025-11-20 | Skip Therapeutics Ltd. | Compositions and methods for treating retinal diseases |
| WO2025240993A1 (en) * | 2024-05-24 | 2025-11-27 | PYC Therapeutics Limited | Improved cell penetrating peptides and related compositions and methods |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6566330B1 (en) | 1996-10-22 | 2003-05-20 | Medical University Of South Carolina Foundation Research Development | Positively charged non-natural amino acids, methods of making and using thereof in peptides |
| US6551795B1 (en) | 1998-02-18 | 2003-04-22 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics |
| JP2004520803A (ja) | 2000-04-21 | 2004-07-15 | コリクサ コーポレイション | 尋常性挫瘡の治療および診断のための組成物および方法 |
| US7214786B2 (en) * | 2000-12-14 | 2007-05-08 | Kovalic David K | Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
| US20060107345A1 (en) * | 2003-09-30 | 2006-05-18 | Nickolai Alexandrov | Sequence-determined DNA fragments and corresponding polypeptides encoded thereby |
| US20160340683A1 (en) | 2007-06-07 | 2016-11-24 | Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Agriculture And Agr | Nanocarrier based plant transfection and transduction |
| NZ704191A (en) * | 2010-06-14 | 2016-05-27 | Hoffmann La Roche | Cell-penetrating peptides and uses therof |
| KR102046830B1 (ko) * | 2011-05-13 | 2019-11-20 | 코벤하븐스 유니버시테트 | 허혈성 뇌 손상에 대한 효과적인 신경보호제이며 통증의 치료를 위한 ｐｓｄ-95의 고-친화성, 이량체 저해제 |
| AU2013316679B2 (en) | 2012-09-13 | 2017-12-14 | Les Hopitaux Universitaires De Geneve | Cell penetrating peptides |
| US10316061B2 (en) * | 2014-10-02 | 2019-06-11 | Temple University Of The Commonwealth System Of Higher Education | Synthesis of cell penetrating peptides for drug delivery and stem cell applications |
| EP3630131B1 (en) * | 2017-06-02 | 2022-08-31 | Arizona Board of Regents on behalf of Arizona State University | A method to create personalized canine cancer vaccines |
| US20210087238A1 (en) * | 2017-07-28 | 2021-03-25 | Phylogica Limited | Cell penetrating peptides and related compositions and methods |
| CA3161901A1 (en) | 2019-12-20 | 2021-06-24 | Shane Stone | Novel cellular delivery methods |
| WO2025043278A1 (en) | 2023-08-25 | 2025-03-06 | PYC Therapeutics Limited | Gene-mediated conditions |
-
2020
- 2020-12-18 CA CA3161901A patent/CA3161901A1/en active Pending
- 2020-12-18 WO PCT/AU2020/051397 patent/WO2021119756A1/en not_active Ceased
- 2020-12-18 EP EP20901124.6A patent/EP4077354A4/en active Pending
- 2020-12-18 BR BR112022012057A patent/BR112022012057A2/pt unknown
- 2020-12-18 IL IL294050A patent/IL294050A/en unknown
- 2020-12-18 US US17/786,671 patent/US12698307B2/en active Active
- 2020-12-18 KR KR1020227025063A patent/KR20220117914A/ko active Pending
- 2020-12-18 JP JP2022538169A patent/JP7684971B2/ja active Active
- 2020-12-18 CN CN202080093916.XA patent/CN115190884B/zh active Active
- 2020-12-18 AU AU2020406670A patent/AU2020406670B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5747100B2 (ja) | 抗菌化合物および処方物 | |
| WO2020069445A1 (en) | Lipid nanoparticle formulations comprising lipidated cationic peptide compounds for nucleic acid delivery | |
| CN103998458B (zh) | 具有中央疏水域的细胞穿透肽 | |
| Sakagami et al. | Importance of net hydrophobicity in the cellular uptake of all-hydrocarbon stapled peptides | |
| JP7846169B2 (ja) | 細胞透過性ペプチド | |
| JP2008521759A (ja) | ＢＨ３−ｏｎｌｙタンパク質のＢＨ３ドメイン配列を含む融合タンパク質 | |
| JP2022512977A (ja) | ミニヌクレオソームコアタンパク質及び核酸送達における使用 | |
| WO2018106273A1 (en) | Collagen targeting nanofibers and nanosheets | |
| TW202108603A (zh) | Ｍａｓｐ抑制性化合物及其用途 | |
| CN110248953A (zh) | 新型订书肽及其用途 | |
| WO2002020561A1 (en) | Novel polypeptides and anti-hiv drugs containing the same | |
| US10669313B2 (en) | Multitarget-directed bio-inorganic hybrid structure | |
| CA3196066A1 (en) | Shuttle agent peptides of minimal length and variants thereof adapted for transduction of cas9-rnp and other nucleoprotein cargos | |
| WO2013134249A1 (en) | Adipose tissue targeted peptides | |
| CN115552013A (zh) | 修饰的微核小体核心蛋白及其在核酸递送中的用途 | |
| Bang et al. | Targeted delivery of self-assembled nanocomplex between fusion peptides and siRNAs for breast cancer treatment | |
| Yang et al. | The structure and configuration changes of multifunctional peptide vectors enhance gene delivery efficiency | |
| RU2620070C2 (ru) | Модифицированные пептиды и их применение для лечения аутоиммунных заболеваний | |
| AU2021362834A1 (en) | Peptide-based transduction of non-anionic polynucleotide analogs for gene expression modulation | |
| TW201919682A (zh) | 活化Ｎｒｆ２路徑的新穎化合物 | |
| EP2108698A1 (en) | Vascular endothelial cell-binding peptide | |
| JP7302887B2 (ja) | 抗がんペプチド及びその使用 | |
| CN113750248B (zh) | 病理识别分子-药物偶合物及其应用 | |
| Bang et al. | Targeted Delivery of siRNA through Nanocomplex using Specific Fusion Peptides for Breast Cancer Treatment | |
| CN120435304A (zh) | Ccr2抑制剂及使用方法 |